Edwards Lifesciences Corporation (NYSE:EW - Get Free Report) VP Daniel Lippis sold 619 shares of the company's stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $87.51, for a total value of $54,168.69. Following the completion of the transaction, the vice president owned 40,034 shares in the company, valued at $3,503,375.34. This represents a 1.52% decrease in their position. The sale was disclosed …